Tuesday,Regenxbio Inc. (RGNX) announced the appointment of Mitchell Chan as executive vice president and chief financial officer, effective September 17, 2024.
Chan takes over from Vit Vasista, who will remain with the Company as an advisor until January 3, 2025, to ensure a smooth transition.
Chan, a veteran finance executive, brings nearly 20 years of experience in the biotechnology sector, most recently as an Operating Partner at Catalio Capital Management. Before that, he held the position of CFO at Viela Bio.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.